MO4 TRANSFERABILITY OF MODEL-BASED ECONOMIC EVALUATIONS: THE CASE OF TRASTUZUMAB FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE NETHERLANDS
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2008 |
Reihe/Periodikum: | Value in Health ; volume 11, issue 6, page A347 ; ISSN 1098-3015 |
Verlag/Hrsg.: |
Elsevier BV
|
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29174443 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1016/s1098-3015(10)66200-6 |